Goldman Sachs Group Inc Novartis Ag Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,283,233 shares of NVS stock, worth $245 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,283,233

Previous 3,486,231 34.51%

Holding current value

$245 Million

Previous $401 Million 44.59%

% of portfolio

0.04%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$96.78 - $117.18 $116 Million - $141 Million	-1,202,998 Reduced 34.51%	2,283,233 $222 Million
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $43 Million - $49 Million	405,155 Added 13.15%	3,486,231 $401 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $2.01 Million - $2.33 Million	21,715 Added 0.71%	3,081,076 $328 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $45.4 Million - $51.7 Million	-476,541 Reduced 13.48%	3,059,361 $296 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $70.3 Million - $77.3 Million	761,545 Added 27.45%	3,535,902 $357 Million
Q3 2023 May 14, 2024	SELL	$94.73 - $105.13 $72.1 Million - $80.1 Million	-761,545 Reduced 21.54%	2,774,357 $283 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $11.7 Million - $12.9 Million	-123,107 Reduced 4.25%	2,774,357 $283 Million
Q2 2023 May 14, 2024	SELL	$92.52 - $104.91 $162 Million - $183 Million	-1,747,915 Reduced 37.63%	2,897,464 $292 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $162 Million - $183 Million	-1,747,915 Reduced 37.63%	2,897,464 $292 Million
Q1 2023 May 14, 2024	BUY	$80.03 - $92.81 $222 Million - $257 Million	2,768,876 Added 147.56%	4,645,379 $427 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $222 Million - $257 Million	2,768,876 Added 147.56%	4,645,379 $427 Million
Q4 2022 May 14, 2024	SELL	$75.55 - $92.52 $61.1 Million - $74.8 Million	-808,960 Reduced 30.12%	1,876,503 $170 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $61.1 Million - $74.8 Million	-808,960 Reduced 30.12%	1,876,503 $170 Million
Q3 2022 May 14, 2024	BUY	$74.61 - $87.26 $3.74 Million - $4.37 Million	50,131 Added 1.9%	2,685,463 $204 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $3.74 Million - $4.37 Million	50,131 Added 1.9%	2,685,463 $204 Million
Q2 2022 May 14, 2024	SELL	$80.52 - $93.75 $72.5 Million - $84.4 Million	-900,570 Reduced 25.47%	2,635,332 $223 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $11.8 Million - $13.7 Million	-146,264 Reduced 5.26%	2,635,332 $223 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $47.6 Million - $53.8 Million	594,194 Added 27.16%	2,781,596 $244 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $8.68 Million - $9.6 Million	108,936 Added 5.24%	2,187,402 $191 Million
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $170 Million - $198 Million	2,078,466 New	2,078,466 $170 Million

Others Institutions Holding NVS

# of Institutions

1,473

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $231B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Novartis Ag Transaction History